Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

Conditions:   Anaemia;   Chronic Kidney Disease (CKD)Intervention:   Sponsor:   AmgenRecruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials